Evidence map›Paper›PMID 39926150›Full record

ArticleJournal of medical physics

Evaluating the Predictive Value of the Dose-volume Parameters and Vascular Endothelial Growth Factor Expression on Rectal Toxicity in Prostate Cancer Patients.

Marziyeh Mirzaeiyan, Hossein Khanahmad, Simin Hemati, Mahnaz Etehadtavakol, Zahra Sharifonnasabi, Parvaneh Shokrani

Abstract read
In one paragraph

Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marziyeh MirzaeiyanDepartment of Medical Physics, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Hossein KhanahmadDepartment of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Simin HematiDepartment of Radiotherapy Oncology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Mahnaz EtehadtavakolDepartment of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Zahra SharifonnasabiDepartment of Statistics, University of Isfahan, Isfahan, Iran.
Parvaneh ShokraniDepartment of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The response to radiation varies widely among people. Despite recent advances to conform the dose distribution to the tumor volume, it is still impossible to perform radiotherapy based on the biological characteristics of each individual. In this case, identifying a biomarker can be a step toward personalizing treatment. This research was carried out to evaluate the predictive value of dose-volume parameters and vascular endothelial growth factor (VEGF) expression on rectal proctitis toxicity in prostate cancer patients. Materials and Methods: Eighteen patients with prostate cancer who underwent helical tomotherapy were included in the study. VEGF serum level before and after treatment was obtained. Furthermore, dosimetric parameters, including rectal volume, maximum dose, V50, V60, V65, V70, and V75 were extracted. Spearman's correlation coefficient of VEGF-related and dosimetric parameters with the grade ≥1 rectal proctitis was calculated. Results: In the rectal toxicity group, the mean value of VEGF increased significantly after treatment compared to before ( Conclusion: The results of the study confirm the correlation of VEGF expression with the pathobiology process of rectal radiation proctitis. However, the pathobiology process of radiation proctitis is complicated. More research is needed to prove the involvement of VEGF expression in the early detection of proctitis.

Indexed as

Biomarkersproctitisprostatic neoplasmsrectumvascular endothelial growth factors

Identifiers

PMID39926150
PMCPMC11801083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.